Polimunol 40 mg


Download pdf


Each prefilled syringe contains 40 mg glatiramer acetate.

Mechanism of Action:



First, clearly defined clinical episode of multiple sclerosis or clinical syndrome suggestive of MS. It reduces relapses in ambulatory patients with relapsing-remitting multiple sclerosis.

Dosage and Administration:

1 prefilled syringe is applied subcutaneously, three times a week.

Package Size

Packages contain 12 prefilled syringes with 1 ml solution for injection.

Exclusive content for Professionals

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
New User Registration
*Required field